For more than 80 years, men have been told that testosterone helps prostate cancer grow. But a very different picture has ...

Akeega combines niraparib, a PARP inhibitor, and abiraterone acetate, a CYP17 inhibitor, into a single tablet for BRCA2-mutated mCSPC.

By Oluseye OjoIn Nigeria, prostate cancer is a silent killer of men, claiming approximately 31 lives daily.In 2022, records showed that the country recorded 18,019 new cases, resulting in 11,443 ...

Here are the top 5 stories from 2025 about the advancements in prostate, kidney, and bladder cancers.

Instead, he chose to be the first person in Texas to try Inlexzo. Inlexzo is a chemotherapy that comes in a tube that looks ...

King Charles on Friday revealed that doctors have scaled back his cancer treatment plan after what he described as a positive response during an emotional televised address. "Today I am able to share ...

A prostate-specific antigen (PSA) test is a blood test that measures a protein released in the blood by prostate cells. Both normal and cancerous prostate cells release the protein. Most of the time, ...

The tests have not been approved by federal regulators, but that hasn’t stopped patients from wanting them — and doctors from worrying. By Nina Agrawal In the spring of 2021, the cancer field was ...

This satellite symposium took place on 19 th October 2025, as part of the European Society for Medical Oncology (ESMO) Congress held in Berlin, Germany This satellite symposium at the European Society ...

Here’s a PSA about PSA—meaning a public service announcement about prostate specific antigen. Although checking the PSA levels in your blood is a routine way of screening for prostate cancer, just ...

This story was produced by the State College regional bureau of Spotlight PA, an independent, nonpartisan newsroom dedicated to investigative and public-service journalism for Pennsylvania. Sign up ...

A new study has uncovered promising therapeutic strategies against one of the deadliest forms of prostate cancer. McGill University researchers at the Rosalind and Morris Goodman Cancer Institute (GCI ...